Literature DB >> 12652095

HDL genetics: candidate genes, genome wide scans and gene-environment interactions.

Jose M Ordovas1.   

Abstract

Cardiovascular disease (CVD) is multifactorial and its manifestation is determined by interactions among genes, as well as among genetic factors and numerous environmental factors. It has long been known that low levels of high density lipoprotein cholesterol (HDL-C) are associated with increased CVD risk. Moreover, the emerging data from developing countries, suggest that this may be the most common lipid abnormality observed in those societies. It has been clearly demonstrated that variation at several candidate genes has a significant effect over the spectrum of HDL-C levels observed in the general population. In addition, these effects are modulated by several non-modifiable such as gender and age, and modifiable factors, such as diet, smoking, obesity, and alcohol intake among many others. The lessons that we are learning from studying candidate gene-environment interactions should help us to chart the intricacies of the biochemical pathways involved in lipoprotein metabolism. Moreover, similar models need to be applied to the analysis of genome wide searches aimed to uncover new genes involved in HDL metabolism and reverse cholesterol transport. This knowledge should facilitate more targeted and effective public health policies, especially in developing countries, where the fast environmental changes are modifying the disease patterns by exposing a large number of susceptible individuals to the factors that have been responsible for the high prevalence of CVD in Western industrialized countries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12652095     DOI: 10.1023/a:1021769523568

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  11 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 2.  Genetic variation and lipid metabolism: modulation by dietary factors.

Authors:  Jose M Ordovas; Dolores Corella
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 3.  Common variation in genes involved in HDL metabolism influences coronary heart disease risk at the population level.

Authors:  Margaret E Brousseau
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

4.  Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia.

Authors:  France Gagnon; Gail P Jarvik; Michael D Badzioch; Arno G Motulsky; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

5.  Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol.

Authors:  Brian H Shirts; Michael T Howard; Sandra J Hasstedt; M Nazeem Nanjee; Stacey Knight; John F Carlquist; Jeffrey L Anderson; Paul N Hopkins; Steven C Hunt
Journal:  Atherosclerosis       Date:  2012-03-01       Impact factor: 5.162

6.  Nutrients: the environmental regulation of cardiovascular gene expression.

Authors:  Marilena Minieri; Paolo Di Nardo
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

7.  The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment.

Authors:  Jennifer A Smith; Donna K Arnett; Reagan J Kelly; Jose M Ordovas; Yan V Sun; Paul N Hopkins; James E Hixson; Robert J Straka; James M Peacock; Sharon L R Kardia
Journal:  Eur J Hum Genet       Date:  2008-01-23       Impact factor: 4.246

8.  Association of rs2072183 SNP and serum lipid levels in the Mulao and Han populations.

Authors:  Lin Miao; Rui-Xing Yin; Xi-Jiang Hu; Dong-Feng Wu; Xiao-Li Cao; Qing Li; Ting-Ting Yan; Lynn Htet Htet Aung; Jin-Zhen Wu; Wei-Xiong Lin
Journal:  Lipids Health Dis       Date:  2012-05-30       Impact factor: 3.876

Review 9.  Pharmacogenetics of lipid diseases.

Authors:  Jose M Ordovas
Journal:  Hum Genomics       Date:  2004-01       Impact factor: 4.639

10.  CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.

Authors:  C C White; Q Feng; L A Cupples; J V Gainer; E P Dawson; R A Wilke; N J Brown
Journal:  Pharmacogenomics J       Date:  2011-09-13       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.